Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
1.200
-0.020 (-1.64%)
Sep 18, 2024, 4:00 PM EDT - Market closed

Company Description

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally.

It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.

The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.

The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead.

Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Ekso Bionics Holdings, Inc.
Ekso Bionics Holdings logo
Country United States
Founded 2005
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 72
CEO Scott Davis

Contact Details

Address:
101 Glacier Point, Suite A
San Rafael, California 94901
United States
Phone 510 984 1761
Website eksobionics.com

Stock Details

Ticker Symbol EKSO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001549084
CUSIP Number 282644301
ISIN Number US2826443010
SIC Code 3569

Key Executives

Name Position
Scott G. Davis Chief Executive Officer and Director
Jerome Wong Corporate Controller, Corporate Secretary and Chief Financial Officer
Jason C. Jones Chief Operating Officer
Rachael Anderson Global Director of Marketing and Strategic Growth
Ann Cookson Human Resources Director
Foon Lim Chwee President of APAC
Stephan Aderhold Senior Vice President and GM of EMEA

Latest SEC Filings

Date Type Title
Sep 12, 2024 SCHEDULE 13G Filing
Sep 3, 2024 8-K Current Report
Aug 30, 2024 424B4 Prospectus
Aug 29, 2024 EFFECT Notice of Effectiveness
Aug 28, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Jul 29, 2024 10-Q Quarterly Report
Jul 29, 2024 S-8 Securities to be offered to employees in employee benefit plans
Jul 29, 2024 8-K Current Report
Jul 29, 2024 S-1 General form for registration of securities under the Securities Act of 1933
Jul 26, 2024 8-K/A [Amend] Current report